Literature DB >> 12644926

Cardiac ischemia during hemolytic uremic syndrome.

Meena Thayu1, Wayne L Chandler, Srdjan Jelacic, Carrie A Gordon, Geoffrey L Rosenthal, Phillip I Tarr.   

Abstract

Increased thrombin generation and impaired fibrinolysis during Escherichia coli O157:H7-associated hemolytic uremic syndrome (HUS) plausibly diminish myocardial blood flow, but the frequency of cardiac ischemia during HUS is unknown. We identified a 9-year-old boy with HUS in whom myocardial diastolic dysfunction was demonstrated by echocardiography, who also had elevated serum troponin-I and creatine kinase MB mass. However, eight additional patients with HUS did not have elevated markers of cardiac injury. When present, elevated troponin-I should be considered to represent myocardial injury, and not attributed simply to renal insufficiency. It is possible that myocardial ischemia and secondary arrhythmias account for some sudden deaths that occur during acute HUS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644926     DOI: 10.1007/s00467-002-1039-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  18 in total

1.  Cardiopulmonary events during hemodialysis: effects of dialysis membranes and dialysate buffers.

Authors:  M A Munger; A Ateshkadi; A K Cheung; K K Flaharty; G J Stoddard; E H Marshall
Journal:  Am J Kidney Dis       Date:  2000-07       Impact factor: 8.860

2.  von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome.

Authors:  H M Tsai; W L Chandler; R Sarode; R Hoffman; S Jelacic; R L Habeeb; S L Watkins; C S Wong; G D Williams; P I Tarr
Journal:  Pediatr Res       Date:  2001-05       Impact factor: 3.756

3.  Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis.

Authors:  F S Apple; S W Sharkey; P Hoeft; R Skeate; E Voss; B A Dahlmeier; L M Preese
Journal:  Am J Kidney Dis       Date:  1997-03       Impact factor: 8.860

4.  Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study.

Authors:  M C Iliou; C Fumeron; M O Benoit; P Tuppin; C L Courvoisier; V M Calonge; N Moatti; C Buisson; C Jacquot
Journal:  Nephrol Dial Transplant       Date:  2001-07       Impact factor: 5.992

5.  Clinical evaluation of the ACS:180 cardiac troponin I assay.

Authors:  P O Collinson; N Wiggins; D C Gaze
Journal:  Ann Clin Biochem       Date:  2001-09       Impact factor: 2.057

6.  Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome.

Authors:  Wayne L Chandler; Srdjan Jelacic; Daniel R Boster; Marcia A Ciol; Glyn D Williams; Sandra L Watkins; Takashi Igarashi; Phillip I Tarr
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

Review 7.  Causes of death in hemolytic uremic syndrome.

Authors:  W L Robson; A K Leung; M D Montgomery
Journal:  Child Nephrol Urol       Date:  1991

8.  The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies.

Authors:  N C van de Kar; V W van Hinsbergh; E J Brommer; L A Monnens
Journal:  Pediatr Res       Date:  1994-08       Impact factor: 3.756

9.  Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers.

Authors:  J R Brandt; L S Fouser; S L Watkins; I Zelikovic; P I Tarr; V Nazar-Stewart; E D Avner
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

10.  Plasminogen activator inhibitor activity in diarrhoea-associated haemolytic uraemic syndrome.

Authors:  I D Chant; D V Milford; P E Rose
Journal:  QJM       Date:  1994-12
View more
  10 in total

1.  Azithromycin decolonization of STEC--a new risk emerges.

Authors:  Michael E Seifert; Phillip I Tarr
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

2.  Acute Myocarditis and Eculizumab Caused Severe Cholestasis in a 17-Month-Old Child Who Has Hemolytic Uremic Syndrome Associated with Shiga Toxin-Producing Escherichia coli.

Authors:  Osman Yesilbas; Can Yilmaz Yozgat; Nurver Akinci; Sirin Sonmez; Eser Tekin; Faraz Talebazadeh; Uzeyir Jafarov; Hafize Otcu Temur; Yilmaz Yozgat
Journal:  J Pediatr Intensive Care       Date:  2020-08-05

3.  Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure.

Authors:  Varvara Askiti; Kristine Hendrickson; Alfred J Fish; Elizabeth Braunlin; Alan R Sinaiko
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

Review 4.  Direct cardiac involvement in childhood hemolytic-uremic syndrome: case report and review of the literature.

Authors:  Davide Rigamonti; Giacomo D Simonetti
Journal:  Eur J Pediatr       Date:  2016-09-23       Impact factor: 3.183

5.  Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).

Authors:  Myda Khalid; Sharon Andreoli
Journal:  Pediatr Nephrol       Date:  2018-11-01       Impact factor: 3.714

6.  HUS-induced cardiac and circulatory failure is reversible using cardiopulmonary bypass as rescue.

Authors:  René F Andersen; Jesper V Bjerre; Johan V Povlsen; Mette Veien; Konstantinos Kamperis; Søren Rittig
Journal:  Pediatr Nephrol       Date:  2017-08-05       Impact factor: 3.714

Review 7.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

8.  Cardiac Manifestation among Children with Hemolytic Uremic Syndrome.

Authors:  Emily Sanders; Clare C Brown; Richard T Blaszak; Brendan Crawford; Parthak Prodhan
Journal:  J Pediatr       Date:  2021-04-02       Impact factor: 6.314

Review 9.  Extra-renal manifestations of complement-mediated thrombotic microangiopathies.

Authors:  Johannes Hofer; Alejandra Rosales; Caroline Fischer; Thomas Giner
Journal:  Front Pediatr       Date:  2014-09-08       Impact factor: 3.418

Review 10.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.

Authors:  Adrien Joseph; Aurélie Cointe; Patricia Mariani Kurkdjian; Cédric Rafat; Alexandre Hertig
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.